Clinical Trial

Effect of Tegileridine Versus Sufentanil as Analgesic Components on Opioid-Induced Cough During Anesthesia Induction

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 8, 2026 (before its estimated August 16, 2026 completion). Its status may not reflect the trial's current state.
Summary
In patients undergoing general anesthesia with planned tracheal intubation , a prospective, randomized, controlled study was conducted to record the occurrence of cough 2 minutes after injection of Sufentanil or Tegilerdine. The cough was graded based on the frequency and duration: Grade I, no cough; Grade II, a single mild cough; Grade III, multiple coughs with duration \<1 second; Grade IV, continuous coughing with a duration \>15 seconds.
Protocol Amendment History 1 change
critical Trial completed 2026-06-17
Trial Details
NCT Number NCT07323043
Lead Sponsor The First People's Hospital of Lianyungang
Conditions General Anesthetic Drug Adverse Reaction
Enrollment 190 participants
Start Date 2026-01-15
Primary Completion 2026-08-16 (estimated)
Study Completion 2026-10-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-08